USA Financial Formulas Sells 1,581 Shares of Colgate-Palmolive (NYSE:CL)

USA Financial Formulas lessened its holdings in shares of Colgate-Palmolive (NYSE:CLFree Report) by 9.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,126 shares of the company’s stock after selling 1,581 shares during the period. Colgate-Palmolive makes up 0.2% of USA Financial Formulas’ portfolio, making the stock its 24th biggest position. USA Financial Formulas’ holdings in Colgate-Palmolive were worth $1,570,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of CL. E Fund Management Hong Kong Co. Ltd. acquired a new position in shares of Colgate-Palmolive in the second quarter valued at approximately $25,000. Continuum Advisory LLC increased its holdings in Colgate-Palmolive by 46.5% during the 2nd quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock worth $38,000 after purchasing an additional 125 shares in the last quarter. Rise Advisors LLC acquired a new stake in shares of Colgate-Palmolive in the 1st quarter valued at about $38,000. Voisard Asset Management Group Inc. bought a new stake in shares of Colgate-Palmolive in the fourth quarter valued at about $40,000. Finally, Register Financial Advisors LLC acquired a new position in shares of Colgate-Palmolive during the first quarter worth about $48,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities research analysts have commented on CL shares. TD Cowen boosted their target price on Colgate-Palmolive from $110.00 to $115.00 and gave the company a “buy” rating in a research note on Tuesday, July 30th. Barclays raised their target price on shares of Colgate-Palmolive from $91.00 to $96.00 and gave the company an “equal weight” rating in a research report on Monday, July 29th. Bank of America boosted their price target on shares of Colgate-Palmolive from $100.00 to $110.00 and gave the stock a “buy” rating in a research report on Wednesday, July 10th. HSBC restated a “hold” rating on shares of Colgate-Palmolive in a report on Friday, July 26th. Finally, Evercore ISI increased their price target on Colgate-Palmolive from $100.00 to $106.00 and gave the company an “outperform” rating in a research report on Thursday, July 18th. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and fourteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $104.74.

View Our Latest Stock Report on CL

Colgate-Palmolive Trading Up 0.4 %

Shares of NYSE:CL opened at $100.98 on Thursday. The company has a quick ratio of 0.70, a current ratio of 1.06 and a debt-to-equity ratio of 16.90. The stock has a market cap of $82.85 billion, a PE ratio of 31.96, a P/E/G ratio of 3.62 and a beta of 0.40. The business has a 50 day moving average of $103.65 and a 200-day moving average of $97.05. Colgate-Palmolive has a 12-month low of $68.54 and a 12-month high of $109.30.

Colgate-Palmolive (NYSE:CLGet Free Report) last released its quarterly earnings results on Friday, July 26th. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.87 by $0.04. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. The business had revenue of $5.06 billion for the quarter, compared to analyst estimates of $5 billion. During the same period last year, the firm earned $0.77 earnings per share. Colgate-Palmolive’s revenue for the quarter was up 4.9% compared to the same quarter last year. As a group, equities research analysts forecast that Colgate-Palmolive will post 3.57 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be issued a $0.50 dividend. The ex-dividend date is Friday, October 18th. This represents a $2.00 annualized dividend and a yield of 1.98%. Colgate-Palmolive’s dividend payout ratio is presently 63.29%.

Insider Activity

In related news, Director Martina Hundmejean sold 2,313 shares of the business’s stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the transaction, the director now owns 11,755 shares of the company’s stock, valued at $1,220,874.30. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of the company’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the sale, the director now directly owns 11,755 shares in the company, valued at $1,220,874.30. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Sally Massey sold 15,850 shares of Colgate-Palmolive stock in a transaction on Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total value of $1,636,988.00. Following the completion of the transaction, the insider now owns 13,942 shares in the company, valued at approximately $1,439,929.76. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 43,490 shares of company stock worth $4,486,063. 0.34% of the stock is currently owned by company insiders.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Stories

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.